PQ 878
878. Deputy Eoin Ó Broin asked the Minister for Health if the HSE drugs group met to consider the revised pricing proposal from the manufacturer of Spinraza; if so, the recommendation of the HSE leadership team; and when the leadership team will make a final decision on the reimbursement of the drug. [19385/19]
Introduced
8 May 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 May 2019
Summary
878. Deputy Eoin Ó Broin asked the Minister for Health if the HSE drugs group met to consider the revised pricing proposal from the manufacturer of Spinraza; if so, the recommendation of the HSE leadership team; and when the leadership team will make a final decision on the reimbursement of the drug. [19385/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 8 May 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-05-08/878/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-05-08/pq_878